LabCorp in talks to buy PPD for $8Bn

By Dani Bancroft contact

- Last updated on GMT

LabCorp in talks to buy the CRO PPD for $8Bn
Unconfirmed reports suggest Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract research organization Pharmaceutical Product Development LLC (PPD).

According to a Reuters report​, a second party is taking part in the auction of PPD with LabCorp, but has not yet been identified​. 

If LabCorp was to acquire PPD, the transaction's value would exceed the $5.7bn for which it purchased Covance​ in 2015.

PPD offers contract research services from inhalation products to biologics​, for a wide range of indications, with headquarters in Wilmington, North Carolina. 

The firm has more than 18,500 employees worldwide and is owned by Carlyle Group LP and Hellman & Friedman LLC, which made the company private in 2011 for $3.9bn.

LabCorp is a North Carolina, US-based clinical lab network with a $14.3bn (€13.3bn) market cap. Last month, it acquired​ Mount Sinai’s clinical outreach laboratories, adding seven patient service centers to its network.

Related news

Show more

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers